| Literature DB >> 30605484 |
Jung-Hwan Cho1, Eun-Jung Rhee1, Se Eun Park1, Hyemi Kwon1, Jin-Hyung Jung2, Kyung-Do Han2, Yong-Gyu Park2, Soon-Jib Yoo3, Yang-Hyun Kim4, Won-Young Lee1.
Abstract
BACKGROUND: Overweight is known as a risk factor for ischemic stroke. However, the effect of weight change on the development of ischemic stroke remains controversial. We investigated the relationship between weight change and the risk of ischemic stroke using a nationwide population-based cohort.Entities:
Mesh:
Year: 2019 PMID: 30605484 PMCID: PMC6317803 DOI: 10.1371/journal.pone.0210153
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flowchart of selection of the final study population.
Baseline characteristics of participants according to changes in weight.
| Characteristics | Change in weight | ||
|---|---|---|---|
| <-5% (n = 1,528,869) | ±5% (n = 7,341,936) | >+5% (n = 2,213,878) | |
| Age (years) | 53.2±14.5 | 50.4±13 | 45±13.5 |
| Age ≥60 years (%) | 544,028 (35.6) | 1,904,085 (25.9) | 367,644 (16.6) |
| Male (%) | 736,584 (48.2) | 4,113,154 (56.0) | 1,246,420 (56.3) |
| Height (cm) | 161.7±9.3 | 163.7±9.1 | 164.9±9.3 |
| Weight (kg) | 59.3±10.7 | 64.1±11.1 | 67.5±12.1 |
| BMI (kg/m2) | 22.6±3.0 | 23.8±3.0 | 24.7±3.3 |
| Waist circumference (cm) | 78.2±8.7 | 80.8±8.8 | 82.2±9.0 |
| Fasting glucose (mg/dL) | 100.5±30.1 | 97.7±21.4 | 95.8±18.4 |
| Systolic BP (mmHg) | 122.3±15.3 | 122.8±14.8 | 122.5±14.5 |
| Diastolic BP (mmHg) | 75.8±9.9 | 76.5±9.9 | 76.6±9.8 |
| Total cholesterol (mg/dL) | 192.7±36.9 | 196.9±36.3 | 198.4±36.7 |
| Triglyceride (mg/dL) | 103.36 (103.27–103.45) | 116.11 (116.06–116.16) | 123.07 (122.97–123.16) |
| HDL-C (mg/dL) | 56.6±18.8 | 54.9±18.4 | 54.4±17.8 |
| LDL-C (mg/dL) | 113.1±42.8 | 116.2±42.8 | 116.7±44.8 |
| GFR (mL/min/1.73 m2) | 87.6±36.2 | 87.3±38.9 | 89.6±41 |
| Current smoker (%) | 335,023 (21.91) | 1,712,054 (23.32) | 567,147 (25.62) |
| Heavy drinker (%) | 98,122 (6.42) | 553,510 (7.54) | 176,778 (7.98) |
| Doing regular physical activity (%) | 328,379 (21.48) | 1,480,134 (20.16) | 357,673 (16.16) |
| Low income (lowest 20%) (%) | 285,225 (18.66) | 1,168,900 (15.92) | 337,931 (15.26) |
| Pre-BMI >25 (%) | 640,843 (41.92) | 2,385,427 (32.49) | 446,683 (20.18) |
| Post-BMI >25 (%) | 294,954 (19.29) | 2,434,674 (33.16) | 950,133 (42.92) |
| Abdominal obesity (%) | 338,469 (22.14) | 2,087,647 (28.43) | 747,600 (33.77) |
| Diabetes (%) | 223,995 (14.65) | 686,533 (9.35) | 138,378 (6.25) |
| Hypertension (%) | 484,962 (31.72) | 2,100,330 (28.61) | 515,544 (23.29) |
| Dyslipidemia (%) | 325,480 (21.29) | 1,565,093 (21.32) | 435,780 (19.68) |
| IHD (%) | 101,846 (6.66) | 375,997 (5.12) | 82,596 (3.73) |
| COPD (%) | 116,338 (7.61) | 449,482 (6.12) | 118,236 (5.34) |
| CKD (%) | 112,953 (7.39) | 453,299 (6.17) | 116,542 (5.26) |
| End stage renal disease (%) | 1,875 (0.12) | 3,363 (0.05) | 1,073 (0.05) |
| Duration (years) | 5.1±1.2 | 5.2±1.2 | 5.1±1.2 |
All data met P <0.0001. Data are presented as means±SD, geometric means (95% confidence intervals), or frequency (%). BMI, body mass index; IHD, ischemic heart disease; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease; BP, blood pressure; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; GFR, glomerular filtration rate; SD, standard deviation
* Defined as a decline in estimated GFR less than 60 mL/min/1.73 m2
Incidence rate and multivariable adjusted HRs (95% CIs) of ischemic stroke (in three groups).
| Subgroups | Frequency | Number of events | IRs (per 1,000 person-years) | Multivariable-adjusted HRs (95% CI) | ||
|---|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | ||||
| Total | ||||||
| <-5% | 1,528,869 | 23,793 | 3.06 | 1.17 (1.16–1.19) | 1.22 (1.20–1.24) | 1.21 (1.19–1.22) |
| ±5% | 7,341,936 | 72,819 | 1.91 | 1 (reference) | 1 (reference) | 1 (reference) |
| ≥+5% | 2,213,878 | 16,979 | 1.49 | 1.10 (1.08–1.12) | 1.07 (1.05–1.08) | 1.06 (1.05–1.08) |
| Male | ||||||
| <-5% | 736,584 | 12,290 | 3.26 | 1.18 (1.16–1.20) | 1.21 (1.19–1.24) | 1.20 (1.18–1.23) |
| ±5% | 4,113,154 | 43,068 | 1.99 | 1 (reference) | 1 (reference) | 1 (reference) |
| ≥+5% | 1,246,420 | 9,622 | 1.49 | 1.09 (1.07–1.11) | 1.06 (1.04–1.09) | 1.06 (1.04–1.09) |
| Female | ||||||
| <-5% | 792,285 | 11,503 | 2.87 | 1.16 (1.14–1.19) | 1.23 (1.20–1.26) | 1.21 (1.18–1.24) |
| ±5% | 3,228,782 | 29,751 | 1.79 | 1 (reference) | 1 (reference) | 1 (reference) |
| ≥+5% | 967,458 | 7,357 | 1.50 | 1.11 (1.09–1.14) | 1.07 (1.04–1.10) | 1.07 (1.04–1.10) |
| P for interaction by sex | 0.58 | 0.6101 | 0.7741 | |||
All data met P <0.0001. Model 1 was adjusted for age and sex; Model 2 was adjusted for the variables in Model 1 plus body mass index, smoking, alcohol drinking, regular physical activity, low-income status; Model 3 was adjusted for the variables in Model 2 plus IHD, COPD, and CKD. IR, incidence rate; HRs, hazard ratios; CIs, confidence intervals; IHD, ischemic heart disease; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease
Fig 2Multivariate-adjusted HR of ischemic stroke (in eight groups) using Model 3 (95% confidence intervals) in the entire study population.
Comparison of the multivariable adjusted HRs (95% CIs) for ischemic stroke according to the difference between baseline- and 4-years-prior-to-baseline-BMI levels 4-years-prior-to-baseline-BMI level.
| Baseline-BMI level | Frequency | Number of events | IRs (per 1,000 person-years) | Multivariable-adjusted HRs (95% CI) | |
|---|---|---|---|---|---|
| 1 | |||||
| 1 | 226,541 | 1,633 | 1.42 | 1 (reference) | |
| 2 | 163,945 | 1,005 | 1.21 | 1.06 (0.98–1.15) | |
| 3 | 2,307 | 39 | 3.36 | 1.61 (1.17–2.21) | |
| 4 | 973 | 12 | 2.38 | 1.02 (0.58–1.80) | |
| 5 | 92 | 2 | 4.26 | 2.05 (0.51–8.20) | |
| 2 | |||||
| 1 | 133,715 | 1484 | 2.21 | 0.97 (0.92–1.02) | |
| 2 | 3,409,278 | 28,486 | 1.61 | 1 (reference) | |
| 3 | 765,201 | 6,362 | 1.60 | 1.08 (1.05–1.11) | |
| 4 | 99,944 | 827 | 1.63 | 1.33 (1.24–1.42) | |
| 5 | 1,961 | 31 | 3.10 | 1.59 (1.12–2.26) | |
| 3 | |||||
| 1 | 1,816 | 52 | 5.93 | 1.20 (0.92–1.58) | |
| 2 | 561,342 | 7,373 | 2.54 | 1.07 (1.04–1.10) | |
| 3 | 1,556,689 | 16,185 | 1.99 | 1 (reference) | |
| 4 | 683,507 | 6,581 | 1.86 | 1.11 (1.08–1.15) | |
| 5 | 4,419 | 54 | 2.47 | 2.06 (1.58–2.70) | |
| 4 | |||||
| 1 | 835 | 25 | 6.02 | 1.26 (0.85–1.86) | |
| 2 | 62,737 | 1,214 | 3.838 | 1.21 (1.15–1.29) | |
| 3 | 516,600 | 7,300 | 2.731 | 1.01 (0.99–1.04) | |
| 4 | 2,426,687 | 29,393 | 2.333 | 1 (reference) | |
| 5 | 146,039 | 1,412 | 1.908 | 1.11 (1.05–1.17) | |
| 5 | |||||
| 1 | 92 | 3 | 6.714 | 1.57 (0.51–4.86) | |
| 2 | 1,275 | 23 | 3.627 | 1.11 (0.74–1.68) | |
| 3 | 2,549 | 31 | 2.425 | 0.97 (0.68–1.38) | |
| 4 | 92,780 | 1,411 | 3.002 | 1.07 (1.00–1.14) | |
| 5 | 223,359 | 2,653 | 2.349 | 1 (reference) |
All data met P <0.0001. BMI level 1, BMI <18.5; BMI level 2, 18.5≤ BMI <23.0; BMI level 3, 23.0≤ BMI <25.0; BMI level 4, 25.0≤ BMI <30.0; BMI level 5, BMI ≥30.0. Multivariable adjustment was performed for age, sex, smoking, alcohol drinking, regular physical activity, low-income status, IHD, COPD, and CKD.
P for interaction by pre BMI * post BMI <0.0001
IR, incidence rate; HRs, hazard ratios; CIs, confidence intervals; IHD, ischemic heart disease; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease